Title: Conceptual framework of modern molecular oncology paving the ways for advance targeted therapies for cancer treatments
Author: Major Retd M.Q .Baig
DOI: https://dx.doi.org/10.18535/jmscr/v10i2.12
Abstract
Cancer cells are those cells that overcomes the boundaries of impending unrestricted divisions and will multiply and further sustain aberrations that’s fuel its growth, survival, invasion and migration (metastasis) to established its presence in distant organs. Technologies have emerged that facilitate understanding of pathways which got disturbed leading the cause of cancer genesis it also opens the gate for targeted therapies that targets specific molecules in the pathways of cancer genesis and its further divisions like few examples , Gleeve which inhibits a subset of tyrosin kinase is approved for the treatment of CML,GIST tumors, Irresa which inhibits EGFR used in NSCLC, Herceptin an monoclonal antibody used in her-2 neu positive breast cancer treatment, Valcade, a Proteosome inhibitor that elicits programmed cell death is approved for the treatment of Multiple myeloma treatment .many more drugs are currently under trails .
Keywords: Targeted therapies, Metastasis, Migrations.
References
- Perkins, N. D. Oncogenes, tumor suppressors and p52 NF-B. Oncogene 22,7553–7556 (2003).
- Lin, L., DeMartino, G. N. & Greene, W. C. Cotranslational biogenesis of NF-B p50 by the 26S proteasome. Cell 92, 819–828 (1998).
- Cohen, S., Achbert-Weiner, H. & Ciechanover, A. Dual effects of Bkinase mediated phosphorylation on p105 fate: SCF(TrCP)-dependent degradation and SCF (TrCP)-independent processing. Mol. Cell. Biol. 24, 475–486 (2004).
- Druker Brian J., et al. "Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia." The New England Journal of Medicine 344, no. 14 (2001): 1031–1037.
- Goldman, John M., and Junia V. Melo. "Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia." The New England Journal of Medicine 344, no. 14 (2001): 1084–1086.
- Nowell, P., J. Rowley, and A. Knudson. "Cancer Genetics, Cytogenetics—Defining the Enemy Within." Nature Medicine 4 (October 1998): 1107–1114.